Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors.
Daniel V KalinovskyAlexey V KibardinIrina V KholodenkoElena V SvirshchevskayaIgor I DoroninMariya Vladimirovna KonovalovaMaria V GrechikhinaFedor N RozovSergey S LarinSergey M DeyevRoman V KholodenkoPublished in: Journal for immunotherapy of cancer (2022)
These findings validate the potential of ADCs targeting ganglioside GD2 in treating multiple GD2-expressing solid tumors.
Keyphrases